Related Experiment Video
Updated: Sep 13, 2025

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
Published on: December 7, 2012
Irradiation and beyond: mitigating TA-GVHD in transfusion
Pratham D Patel1, Ethan A Simpson1, Jason P Acker2
1Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, T6G 2R8 Canada.
Transfusion-associated graft-versus-host disease (TA-GVHD) prevention strategies like irradiation can harm red blood cells. Hypothermic storage may offer a safer alternative for preventing TA-GVHD by reducing T cell viability.
Area of Science:
- Hematology
- Immunology
- Transfusion Medicine
Background:
- Transfusion-associated graft-versus-host disease (TA-GVHD) is a rare, fatal complication of allogeneic transfusions.
- It results from donor T lymphocyte activation in susceptible recipients.
- Current prevention methods include leukoreduction and irradiation.
Purpose of the Study:
- To evaluate alternative methods for preventing TA-GVHD.
- To investigate the potential of hypothermic storage as a safer alternative to irradiation.
Main Methods:
- Review of existing literature on TA-GVHD prevention.
- Analysis of the effects of leukoreduction and irradiation on T cells and red blood cells.
- Examination of evidence for hypothermic storage's impact on T cell viability and red blood cell integrity.
Main Results:
- Leukoreduction reduces, but does not eliminate, viable T cells.
- Irradiation effectively inactivates T cells but damages red blood cells, reducing storage life.
- Hypothermic storage shows promise in reducing T cell viability without compromising red blood cell quality.
Conclusions:
- Irradiation, while effective, has significant drawbacks for red blood cell quality.
- Hypothermic storage presents a potential alternative for TA-GVHD prevention.
- Further comparative studies on hypothermic storage versus irradiation are warranted.
More Related Videos
08:52Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Venous Thrombosis III: Interprofessional Care